Inventor · disambiguated record
Nadia Melanie Rupniak
Also filed as: RUPNIAK NADIA · RUPNIAK NADIA MELANIE
22 granted patents·2 pending applications·440 citations·filing 1997–2003
96Inventor score
Top patents by PatentIndex Score
24 records- 0188US6121261AMethod for treating attention deficit disorderMERCK & CO INC·Filed 1998·Granted Sep 19, 2000·102 cites·8 claims
- 0286US5952315AUse of NK-1 receptor antagonists for treating bipolar disordersMERCK SHARP & DOHME·Filed 1997·Granted Sep 14, 1999·34 cites·5 claims
- 0385US5972938AMethod for treating or preventing psychoimmunological disordersMERCK & CO INC·Filed 1998·Granted Oct 26, 1999·62 cites·16 claims
- 0481US6117855AUse of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agentMERCK SHARP & DOHME·Filed 1997·Granted Sep 12, 2000·50 cites·14 claims
- 0578US6649614B2Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent for treatment of depression or anxietyMERCK SHARP & DOHME·Filed 2001·Granted Nov 18, 2003·7 cites·13 claims
- 0678US6319953B1Treatment of depression and anxiety with fluoxetine and an NK-1 receptor antagonistMERCK SHARP & DOHME·Filed 1999·Granted Nov 20, 2001·41 cites·8 claims
- 0774US6242446B1Method for treating attention deficit disorderMERCK & CO INC·Filed 2000·Granted Jun 5, 2001·7 cites·5 claims
- 0873US5929054AUse of NK-1 receptor antagonists for treating sexual dysfunctionsMERCK SHARP·Filed 1997·Granted Jul 27, 1999·41 cites·3 claims
- 0968US6573261B2Method for treating or preventing psychosomatic and psychoimmunologic disordersMERCK & CO INC·Filed 2001·Granted Jun 3, 2003·1 cites·8 claims
- 1067US5977104AUse of NK-1 receptor antagonists for treating bipolar disordersMERCK SHARP & DOHME·Filed 1998·Granted Nov 2, 1999·29 cites·4 claims
- 1165US6114315AUse of NK-1 receptor antagonists for treating major depressive disorders with anxietyMERCK SHARP & DOHME·Filed 1998·Granted Sep 5, 2000·26 cites·4 claims
- 1250US2004097573A1Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammationFiled 2003·Application pending·0 cites
- 1348US5925627AUse of NK-1 receptor antagonists for treating movement disordersMERCK SHARP & DOHME·Filed 1997·Granted Jul 20, 1999·7 cites·11 claims
- 1443US6271230B1Use of NK-1 receptor antagonists for treating cognitive disordersMERCK SHARP & DOHME·Filed 1999·Granted Aug 7, 2001·6 cites·5 claims
- 1543US6100256AUse of NK-1 receptors antagonists for treating schizophrenic disordersMERCK SHARP & DOHME·Filed 1998·Granted Aug 8, 2000·7 cites·11 claims
- 1643US2002142942A1Method for treating premenstrual or late luteal phase syndromeMERCK & CO INC·Filed 2002·Application pending·0 cites
- 1741US5919781AUse of NK-1 receptor antogonists for treating substance use disordersMERCK SHARP & DOHME·Filed 1997·Granted Jul 6, 1999·5 cites·6 claims
- 1840US5952330AUse of NK-1 receptor antagonists for treating maniaMERCK SHARP & DOHME·Filed 1997·Granted Sep 14, 1999·4 cites·4 claims
- 1939US6156749AUse of NK-1 receptor antagonists for treating movement disordersMERCK SHARP & DOHME·Filed 1999·Granted Dec 5, 2000·4 cites·13 claims
- 2038US6087348AUse of NK-1 receptor antagonists for treating stress disordersMERCK SHARP & DOHME·Filed 1999·Granted Jul 11, 2000·3 cites·15 claims
- 2137US6232311B1Method for treating or preventing psychosomatic and psychoimmunologic disordersMERCK & CO INC·Filed 1999·Granted May 15, 2001·3 cites·6 claims
- 2234US6090819AUse of NK-1 receptor antagonists for treating maniaMERCK SHARP & DOHME·Filed 1999·Granted Jul 18, 2000·1 cites·2 claims
- 2333US6613765B1Use of NK-1 receptor antagonists for treating major depressive disordersMERCK SHARP & DOHME·Filed 1998·Granted Sep 2, 2003·0 cites·8 claims
- 2431US6096729AUse of NK-1 receptor antagonists for treating amnestic disordersMERCK SHARP & DOHME·Filed 1997·Granted Aug 1, 2000·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →